← All trials
NCT02645916
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2015
- Primary completion
- Aug 1, 2017
- Completion date
- Aug 1, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 66
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Gachon UniversityLead sponsor
- Gachon UniversityReponsible party - principal investigator
- Dongguk UniversityCollaborator
- Kyung Hee UniversityCollaborator
- Sangji UniversityCollaborator
- Semyung UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.